Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Warner-Lambert
Current Parent CompanyPfizer
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $190,000,000
Year: 2004
Date: May 13, 2004
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Mega-ScandalImproper Drug Marketing
Violation Description: Warner-Lambert, a subsidiary of Pfizer, agreed to pay $190 million to resolve multistate litigation relating to the marketing of its drug Neurontin for uses not approved by the Food and Drug Administration. The total included $152 million to be paid to state Medicaid programs and $38 million to state consumer fraud offices. All this was part of a larger $430 million civil and criminal settlement also involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.